Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Afatinib, an irreversible ErbB1 / HER-1 / EGFR tyrosine kinase inhibitors, combined with the EGFR monoclonal antibody cetuximab, was previously demonstrated to overcome resistance to EGFR TKIs
…